To include your compound in the COVID-19 Resource Center, submit it here.

Medco: cancer drug spending could rise 42% by 2013

Pharmacy benefit manager Medco Health Solutions Inc. (NYSE:MHS) said an increase

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE